研究業績-2019|糖尿病 食事療法 治療 京大病院 栄養内科





研究業績

Murakami T, Yabe D, Inagaki N. Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology. J Diabetes Investig. 2019 Sep;10(5):1168-1170. (doi : 10.1111/jdi.13060)

Fujita. Y, Inagaki N. An update on efficacy and safety of SGLT2 inhibitors in Asians and non-Asians. J Diabetes Investig. 2019. (doi: 10.1111/jdi.13150)

Suzuki K, Fukushima M, Inagaki N. Are there any sensors in oral cavity for gut hormone release? Curr Oral Health Rep. e-ISSN 2196-3002, 2019. (doi: 10.1007/s40496-019-0218-2)

Fujita H, Murakami T, Tomoike F, Yabe D , Inagaki N. Ceritinib-associated hyperglycemia in the Japanese Adverse Drug Event Report Database. J Diabetes Investig. 2019. (doi:10.1111/jdi.13168)

Minamino H, Katsushima M, Yoshida T, Hashimoto M, Fujita Y, Shirakashi M, Yamamoto W, Murakami K, Murata K, Nishitani K, Tanaka M, Ito H, Inagaki N, Matsuda S. Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database. PLoS One. 15(3): e0229998, 2020 (doi: 10.1371/journal.pone.0229998)

Hasegawa, T., Komagata, M., Hamasaki, A., Harada, N., Seino, Y., and Inagaki, N. Solid-phase extraction treatment is required for measurement of active glucagon-like peptide-1 by enzyme-linked immunosorbent assay kit affected by heterophilic antibodies. J. Diabetes Investig. 10: 302-308, 2019.

Asai, T., Takahashi, A., Ito, K., Uetake, T., Matsumura, Y., Ikeda, K., Inagaki, N., Nakata, M., Imanishi, Y., and Sato, K. Amount of collagen in the meat contained in Japanese daily dishes and the collagen peptide content in human blood after ingestion of cooked fish meat. J. Agric. Food Chem. 67:2831-2838, 2019.

Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. FASEB J. 33(5):6239-6253,2019. (doi: 10.1096/fj.201801783RR. Epub 2019 Feb 21.)

Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, and Naruse M; Japan Primary Aldosteronism Study Group. High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: A large, multicenter cohort study in Japan. Diabetes Care 42: 938-945, 2019. (doi: 10.2337/dc18-1293)

Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim Y H, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N. Incidence, feaures, and prognosis of immune-related adverse events involving the thyroid gland indused by nivolumab. PLoS One. 14(5):e0216954 , 2019. (doi: 10.1371/journal.pone.0216954)

Ueda Y, Yasoda A, Hirota K, Yamauchi I, Yamashita T, Kanai Y, Sakane Y, Fujii T, Inagaki N. Exogenous C-type natriuretic peptide therapy for impaired skeletal growth in a murine model of glucocorticoid treatment. Sci Rep. 2019. (doi: 10.1371/journal.pone.0204172)

Oshima A, Nishimura A, Chen-Yoshikawa T F, Harashima S-I Komatsu T, Handa, T, Aoyama A, Takahashi K, Ikeda M, Oshima Y, Ikezoe K, Sato S, Isomi M, Shide K, Date H, and Inagaki N. Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study. Clin Transplant. 33(6): e13566, Jun, 2019. (doi: 10.1111/ctr.13566)

Murata Y, Harada N, Yamane S, Iwasaki K, Ikeguchi E, Kanemaru Y, Harada T, Sankoda A, Shimazu-Kuwahara S, Joo E, Poudyal H, and Inagaki N. Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet. Am J Physiol Endocrinol Metab. 317: E53-E64, 2019. (doi: 10.1152/ajpendo.00200)

Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Ichijo T, Katabami T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Ogo A, Okamura S, Miyauchi S, Yanase T, Suzuki T, Kawamura T, and Naruse M; JPAS Study Group. Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling. J Hypertens. 37: 1493-1499, 2019. (doi: 10.1097/HJH.0000000000002047)

Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, Ito H, Tsuiki M, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Yanase T, Suzuki T, and Naruse M.; JPAS/JRAS Study Group. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. J Hypertens. 37: 1513-1520, 2019. (doi: 10.1097/HJH.0000000000002070.)

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y. Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, and Naruse M.; JPAS/JRAS Study Group. Association between acute fall in estimated glomerular filtration rate after Ttreatment for primary aldosteronism and long-term decline in renalfunction. Hypertension, 74:630-638, 2019. (doi: 10.1161/HYPERTENSIONAHA.119.13131)

Ohno Y, Sone M, Inagaki N, Takeda Y, Kurihara I, Tsuiki M, Ichijo T, Wada N, Katabami T, Ogawa Y, Okamura S, Fukuoka T, Kai T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Chiba Y, Naruse M; JPAS/JRAS Study Group. Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism. J Clin Endocrinol Metab.104(10):4382-4389,2019. (doi: 10.1210/jc.2018-02790)

Shimazu-Kuwahara S, Kanemaru Y, Harada N, Ikeguchi E, Ueda Y, Yamane S, Murata Y Yasoda A, Kieffer T J, Inagaki N. Glucose-dependent insulinotropic polypeptide deficiency reduced fat accumulation and insulin resistance but deteriorated bone loss in ovariectomized mice. J Diabetes Investig. 10: 909-914, 2019. (doi: 10.1111/jdi.12978.)

Mano F, Ikeda K, Uchida Y, Liu I H, Joo E, Okura M, and Inagaki N. Novel psychosocial factor involved in diabetes self-care in the Japanese cultural context. J Diabetes Investig. 10: 1102-1107, 2019. (doi: 10.1111/jdi.12983)

Shirako S, Kojima Y, Tomari N, Nakamura Y, Matsumura Y, Ikeda K, Inagaki N, and Sato K. Pyroglutamyl leucine, a peptide in fermented foods, attenuates dysbiosis by increasing host antimicrobial peptide. NPJ Sci Food 3: 18, 2019. (doi.org/10.1038/s41538-019-0050-z)

Sankoda A, Harada N, Kato T, Ikeguchi E, Iwasaki K, Yamane S, Murata Y, Hirasawa A, and Inagaki N. Free fatty acid receptor, G protein-coupled receptor 120 and G protein-coupled receptor 40, are essential for oil-induced gastric inhibitory polypeptide secretion. J Diabetes Investig. 10:1430-1437, 2019. (doi: 10.1111/jdi.13059)

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M, JPAS/JRAS Study Group. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism. Eur J Endocrinol. 2019. (doi: 10.1530/EJE-19-0047)

Fujita N, Fujimoto H, Hamamatsu K, Murakami T, Kimura H, Toyoda K, Saji H, Inagaki N. Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4.FASEB J. 33(11)11836-11844:fj201900555RR, 2019. (doi: 10.1096/fj.201900555RR)

Nakamura T, Fujikura J, Anazawa T, Ito R, Ogura M, Okajima H, Uemoto S, and Inagaki, N. Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study. J Diabetes Investig, in press. (doi: 10.1111/jdi.13128)

Kaku K, Araki E, Tanizawa Y, Ross Agner B, Nishida T, Ranthe M, Inagaki N. Superior efficacy with a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin-naive Japanese patients with type 2 diabetes in a phase 3, open-label, randomized trial. Diabetes Obes Metab, 21:2674-2683,2019. (doi: 10.1111/dom.13856)

Murakami T, Fujimoto H, Fujita N, Hamamatsu K, Matsumoto K, Inagaki N. Non-invasive evaluation of GPR119 agonist effects on β-cell mass in diabetic male mice using 111In-exendin-4 SPECT/CT. Endocrinology. 160(12): 2959 2968, 2019. (doi: 10.1210/en.2019-00556)

Inagaki, N., Yang, W., Watada, H., Ji, L., Schnaidt, S., Pfarr, E., Okamura, T., Johansen, O. E., George, J. T., von Eynatten, M., Rosenstock, J., Perkovic, V., Wanner, C., Cooper, M. E., Alexander, J. H., Komuro, I., and Nangaku, M. Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA trial. Diabetol. Int. 11: 129-141, 2019.

Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, and Naruse M.; JPAS Study Group. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan. J Hum Hypertens, in press. (doi: 10.1038/s41371-019-0229-4)

Yokota Y, Fushimi Y, Okada T, Fujimoto K, Oshima S, Nakajima S, Fujii T, Tanji M, Inagaki N, Miyamoto S, and Togashi K. Evaluation of image quality of pituitary dynamic contrast-enhanced MRI using time-resolved angiography with interleaved stochastic trajectories (TWIST) and iterative reconstruction TWIST (IT-TWIST). J Magn Reson. Imaging., in press. (doi:org/10.1002/jmri.26962)

Usui R, Yabe D, Fauzi M, Goto H Botagarova A Tokumoto S, Tatsuoka H, Tahara Y, Kobayashi S, Manabe T, Baba Y, Kurosaki T, Herrera P L, Ogura M, Nagashima K, and Inagaki N. GPR40 activation initiates store-operated Ca2+ entry and potentiates insulin secretion via the IP3R1/STIM1/Orai1 pathway in pancreatic β-cells. Sci Rep, in press. (doi: 10.1038/s41598-019-52048-1)

Hamamatsu K, Fujimoto H, Fujita N, Murakami T, Shiotani M, Toyoda K, Inagaki N. Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with 111In-labeled exendin-4 K. Sci Rep, online. (doi: 10.1038/s41598-019-55808-1)

Takeuchi M, Ogura M, Minoura T, Inagaki N, Kawakami K. Comparative Effectiveness of Sodium-Glucose Contransporter-2 Inhibitors Versus Other Classes of Glucose-Lowering Medications on Renal Outcome in Type 2 Diabetes. Mayo Clinic. (doi: 10.1016/j.mayocp.2019.12.004)